No Data
No Data
Quest Diagnostics: Strong Growth Potential and Resilience Amidst Economic Uncertainty
Quest Diagnostics | 10-Q: Q1 2025 Earnings Report
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
Morgan Stanley Adjusts Quest Diagnostics Price Target to $182 From $172, Maintains Overweight Rating
Jefferies Adjusts Quest Diagnostics Price Target to $195 From $190, Maintains Buy Rating
Quest Diagnostics Is Maintained at In-Line by Evercore ISI Group